Atwater Malick’s Eli Lilly LLY Stock Holding History

Atwater Malick’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$844K	Sell	918 -104	-10%	-$105K	0.23%	48
2025 Q4	$1.1M	Buy	1,022 +4	+0.4%	+$3.83K	0.3%	40
2025 Q3	$777K	Buy	1,018 +13	+1%	+$9.67K	0.23%	45
2025 Q2	$783K	Hold	1,005	–	–	0.25%	47
2025 Q1	$830K	Sell	1,005 -20	-2%	-$16.6K	0.28%	42
2024 Q4	$791K	Buy	1,025 +133	+15%	+$110K	0.27%	42
2024 Q3	$790K	Hold	892	–	–	0.25%	44
2024 Q2	$808K	Hold	892	–	–	0.28%	42
2024 Q1	$694K	Hold	892	–	–	0.24%	44
2023 Q4	$520K	Hold	892	–	–	0.2%	49
2023 Q3	$479K	Hold	892	–	–	0.21%	45
2023 Q2	$418K	Buy	+892	New	+$374K	0.18%	49

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atwater Malick's LLY Position: Q1 2026 in Review

Atwater Malick reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $105K and leaving 918 shares worth $844K. The position accounts for 0.23% of the portfolio, ranked #48.

Atwater Malick first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Atwater Malick held 918 shares of Eli Lilly worth $844K as of Q1 2026.
Atwater Malick sold 104 Eli Lilly shares in Q1 2026, an estimated $105K.
Eli Lilly made up 0.23% of Atwater Malick's portfolio in Q1 2026, its #48 holding.
Atwater Malick first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Atwater Malick's Eli Lilly position peaked at $1.1M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Atwater Malick's 13F filing for Q1 2026, filed 22 Apr 2026.